NCT02528864View on ClinicalTrials.gov

MRI and Metabolomics Biomarkers for Uterine Malignancy

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Uterine Neoplasms
Trial Locations (1)

333

Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Guishan

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT02528864 - MRI and Metabolomics Biomarkers for Uterine Malignancy | Biotech Hunter | Biotech Hunter